Rifabutin
NDC 59762-1350, rifabutin, capsule, from Mylan Pharmaceuticals Inc..
- Product NDC
- 59762-1350
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA050689
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIFABUTIN150 mg/1
Pharmacologic classes
Rifamycin Antimycobacterial [EPC]; Rifamycins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59762-1350-1 | 59762135001 | 100 CAPSULE in 1 BOTTLE (59762-1350-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c2026b67-4755-4236-96b6-a6b5e7399707NADAC price for package 59762135001
GET /v1/drugs/nadac/59762135001
Use it
Look up 59762-1350 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59762-1350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.